Latest Commercialization News

Page 46 of 481
Schaffer Corporation’s first half FY26 profit fell sharply due to a Jaguar Land Rover cyberattack disrupting production, while its South Connect Jandakot property development breaks ground.
Victor Sage
Victor Sage
18 Feb 2026
Star Minerals has entered a strategic partnership with Catalyst Metals, securing a gold milling agreement for its Tumblegum South project and selling its West Bryah Basin copper-gold assets for $2.75 million. Catalyst also commits to a $1 million equity placement in Star Minerals, underpinning the company’s development plans.
Maxwell Dee
Maxwell Dee
18 Feb 2026
INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.
Ada Torres
Ada Torres
18 Feb 2026
Starpharma reports a $1.37 million profit for H1 FY26, driven by a major upfront payment from Genentech and progress in its radiopharmaceutical pipeline. The biotech also expands its consumer health footprint amid growing partnerships.
Ada Torres
Ada Torres
18 Feb 2026
SHAPE Australia Corporation Limited has reported a robust first half of FY26, with significant gains in revenue, profits, and project pipeline, underpinned by strategic sector diversification and a key acquisition.
Victor Sage
Victor Sage
18 Feb 2026
SHAPE Australia Corporation Limited reported a robust half-year performance with a 48.5% rise in net profit and declared a fully franked 14 cent interim dividend, underpinned by strategic acquisition and operational discipline.
Victor Sage
Victor Sage
18 Feb 2026
Euro Manganese Inc. reported progress on its Chvaletice and Bécancour manganese projects, securing funding amendments and advancing permitting despite ongoing financial pressures. The company is positioned to benefit from growing demand for high-purity manganese in lithium-ion batteries amid evolving market dynamics.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Telix Pharmaceuticals has lodged a European marketing authorization application for TLX101-Px, a novel PET imaging agent targeting glioma brain cancer, aiming to enhance diagnostic precision and patient access across major European markets.
Ada Torres
Ada Torres
18 Feb 2026
Euro Manganese Inc. reported a net loss of $3.6 million for Q3 2025 and extended key financing milestones to June 2026, highlighting ongoing challenges in funding its Chvaletice Manganese Project.
Maxwell Dee
Maxwell Dee
18 Feb 2026
5E Advanced Materials reports Q2 FY2026 results with increased mineral resources and key shipments, while navigating ongoing funding uncertainties.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Metals Australia has confirmed extensive high-grade Vanadium-Titanium-Magnetite mineralisation at its Manindi project in Western Australia, alongside promising metallurgical results indicating potential for premium Titanium Dioxide products.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Southern Cross Electrical Engineering reported a strong half-year EBITDA growth of 30.8% despite a $46.1 million legal settlement impacting net profit. The company raised its full-year EBITDA guidance amid a robust project pipeline and ongoing diversification.
Victor Sage
Victor Sage
18 Feb 2026